Article Information
vol. 12 no. 548
PubMed:
Published By:
Print ISSN:
Online ISSN:
History:
- Received for publication April 23, 2020
- Accepted for publication May 29, 2020
- .
Copyright & Usage:
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works http://www.sciencemag.org/about/science-licenses-journal-article-reuseThis is an article distributed under the terms of the Science Journals Default License.
Author Information
- Sangeeta Goswami1,
- Yulong Chen1,
- Swetha Anandhan1,
- Peter M. Szabo2,
- Sreyashi Basu3,
- Jorge M. Blando3,*,
- Wenbin Liu3,
- Jan Zhang1,
- Seanu Meena Natarajan1,
- Liangwen Xiong1,
- Baoxiang Guan1,
- Shalini Singh Yadav3,
- Abdel Saci2,
- James P. Allison3,4,
- Matthew D. Galsky5 and
- Padmanee Sharma1,3,4,†
- 1Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- 2Department of Translational Medicine, Bristol Myers Squibb, Princeton, NJ 08540, USA.
- 3Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- 4Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- 5Division of Hematology and Medical Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai/Tisch Cancer Institute, New York, NY 10029, USA.
- ↵†Corresponding author. Email: padsharma{at}mdanderson.org
